atrasentan



atrasentan


SMILES CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1
InChIKey MOTJMGVDPWRKOC-QPVYNBJUSA-N

Chemical Properties

Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 12
Molecular weight (Da) 510.3


No bioactivity data available.

atrasentan


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Clinical Trials

Phase I
Phase II
Phase III
Approved No


Compound is not listed as a drug.